Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma

Disease recurrence is frequent in high-risk neuroblastoma (NBL) patients even after multi-modality aggressive treatment [a combination of chemotherapy, surgical resection, local radiation therapy, autologous stem cell transplantation, and cis-retinoic acid (CRA)]. Recent clinical studies have explor...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Koehn, Tony A., Trimble, Lori L., Alderson, Kory L., Erbe, Amy K., McDowell, Kimberly A., Grzywacz, Bartosz, Hank, Jacquelyn A., Sondel, Paul M.
Format: Artigo
Langue:Inglês
Publié: Frontiers Research Foundation 2012
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353262/
https://ncbi.nlm.nih.gov/pubmed/22623917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2012.00091
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires